
Quiz|Articles|January 18, 2026
Dermatology Times Spot Test: January 18, 2026
Author(s)Marie Bosslett, Assistant Editor
Listen
0:00 / 0:00
Key Takeaways
- The Spot Test is designed to assess understanding of recent dermatology developments, focusing on essential topics and breakthroughs.
- Readers are encouraged to engage with the content to deepen their knowledge of the latest advancements in dermatology.
Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series!
Advertisement
Welcome to Dermatology Times' Spot Test!
Each week, dive into a series of thought-provoking questions designed to test your understanding of essential topics, trends, and breakthroughs in dermatology. In this edition, we'll focus on some breaking dermatology news shared throughout the week.
Do you have a set of quiz questions to share? Contact editor Marie Bosslett at
Initiation of the phase 1 study of REX-8756 triggered what financial milestone for Recludix?
Which patient populations are included under the approved indication for cosibelimab-ipdl?
What radioactive material is used in Alpha DaRT sources?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
2
Case Report Highlights Rural Care Gaps in Recurrent Merkel Cell Carcinoma
3
Phase 3 STOP-HS Trials Highlight Promise of Oral JAK1 Inhibition for Moderate to Severe Disease
4
Biologic Therapies in AD and CSU: Progress and the Push for Precision Medicine
5











